ERIS Lifesciences consolidated net profit rises 19.05% in the December 2025 quarter
(13 Feb 2026)

Back
Net profit of ERIS Lifesciences rose 19.05% to Rs 99.72 crore in the quarter ended December 2025 as against Rs 83.76 crore during the previous quarter ended December 2024. Sales rose 10.91% to Rs 800.89 crore in the quarter ended December 2025 as against Rs 722.12 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales800.89722.12 11
OPM %35.1634.66 -
PBDT232.93197.36 18
PBT162.59116.36 40
NP99.7283.76 19

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew